rayner intraocular lenses limited
rayner intraocular lenses limited Company Information
Company Number
00615539
Next Accounts
Sep 2025
Shareholders
rayner surgical group ltd
Group Structure
View All
Industry
Manufacture of medical and dental instruments and supplies
Registered Address
10 dominion way, worthing, west sussex, BN14 8AQ
Website
www.rayner.comrayner intraocular lenses limited Estimated Valuation
Pomanda estimates the enterprise value of RAYNER INTRAOCULAR LENSES LIMITED at £187.9m based on a Turnover of £65.9m and 2.85x industry multiple (adjusted for size and gross margin).
rayner intraocular lenses limited Estimated Valuation
Pomanda estimates the enterprise value of RAYNER INTRAOCULAR LENSES LIMITED at £384.5m based on an EBITDA of £21.8m and a 17.68x industry multiple (adjusted for size and gross margin).
rayner intraocular lenses limited Estimated Valuation
Pomanda estimates the enterprise value of RAYNER INTRAOCULAR LENSES LIMITED at £127.3m based on Net Assets of £55.5m and 2.3x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Rayner Intraocular Lenses Limited Overview
Rayner Intraocular Lenses Limited is a live company located in west sussex, BN14 8AQ with a Companies House number of 00615539. It operates in the manufacture of medical and dental instruments and supplies sector, SIC Code 32500. Founded in November 1958, it's largest shareholder is rayner surgical group ltd with a 100% stake. Rayner Intraocular Lenses Limited is a mature, large sized company, Pomanda has estimated its turnover at £65.9m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Rayner Intraocular Lenses Limited Health Check
Pomanda's financial health check has awarded Rayner Intraocular Lenses Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 4 areas for improvement. Company Health Check FAQs
6 Strong
2 Regular
4 Weak
Size
annual sales of £65.9m, make it larger than the average company (£17.9m)
£65.9m - Rayner Intraocular Lenses Limited
£17.9m - Industry AVG
Growth
3 year (CAGR) sales growth of 34%, show it is growing at a faster rate (6.2%)
34% - Rayner Intraocular Lenses Limited
6.2% - Industry AVG
Production
with a gross margin of 62%, this company has a lower cost of product (37.4%)
62% - Rayner Intraocular Lenses Limited
37.4% - Industry AVG
Profitability
an operating margin of 26.4% make it more profitable than the average company (5.9%)
26.4% - Rayner Intraocular Lenses Limited
5.9% - Industry AVG
Employees
with 343 employees, this is above the industry average (90)
343 - Rayner Intraocular Lenses Limited
90 - Industry AVG
Pay Structure
on an average salary of £54.1k, the company has an equivalent pay structure (£49.6k)
£54.1k - Rayner Intraocular Lenses Limited
£49.6k - Industry AVG
Efficiency
resulting in sales per employee of £192.1k, this is equally as efficient (£182.4k)
£192.1k - Rayner Intraocular Lenses Limited
£182.4k - Industry AVG
Debtor Days
it gets paid by customers after 427 days, this is later than average (50 days)
427 days - Rayner Intraocular Lenses Limited
50 days - Industry AVG
Creditor Days
its suppliers are paid after 5319 days, this is slower than average (36 days)
5319 days - Rayner Intraocular Lenses Limited
36 days - Industry AVG
Stock Days
it holds stock equivalent to 172 days, this is more than average (95 days)
172 days - Rayner Intraocular Lenses Limited
95 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 3 weeks, this is less cash available to meet short term requirements (12 weeks)
3 weeks - Rayner Intraocular Lenses Limited
12 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 87.2%, this is a higher level of debt than the average (41.9%)
87.2% - Rayner Intraocular Lenses Limited
41.9% - Industry AVG
RAYNER INTRAOCULAR LENSES LIMITED financials
Rayner Intraocular Lenses Limited's latest turnover from December 2023 is £65.9 million and the company has net assets of £55.5 million. According to their latest financial statements, Rayner Intraocular Lenses Limited has 343 employees and maintains cash reserves of £21.1 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 65,896,000 | 55,110,000 | 36,102,000 | 27,284,000 | 34,159,000 | 31,125,000 | 23,800,000 | 21,476,000 | 19,983,000 | 20,142,000 | 19,512,701 | 18,260,373 | 20,500,009 | 19,280,266 | 15,957,204 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | 25,068,000 | 15,650,000 | 14,969,000 | 11,967,000 | 14,693,000 | 11,988,000 | 9,595,000 | 8,130,000 | 7,653,000 | 6,712,000 | 5,431,945 | 5,245,490 | 6,176,948 | 5,287,591 | 4,868,301 |
| Gross Profit | 40,828,000 | 39,460,000 | 21,133,000 | 15,317,000 | 19,466,000 | 19,137,000 | 14,205,000 | 13,346,000 | 12,330,000 | 13,430,000 | 14,080,756 | 13,014,883 | 14,323,061 | 13,992,675 | 11,088,903 |
| Admin Expenses | 23,458,000 | 22,808,000 | 15,517,000 | 14,896,000 | 16,606,000 | 15,051,000 | 12,512,000 | 10,031,000 | 10,537,000 | 10,651,000 | |||||
| Operating Profit | 17,370,000 | 16,652,000 | 5,616,000 | 421,000 | 2,860,000 | 4,086,000 | 1,693,000 | 3,315,000 | 1,793,000 | 2,779,000 | |||||
| Interest Payable | 1,545,000 | 154,000 | 169,000 | 196,000 | 232,000 | 108,000 | 169,000 | 79,000 | 139,000 | ||||||
| Interest Receivable | 5,000 | ||||||||||||||
| Pre-Tax Profit | 15,825,000 | 16,498,000 | 5,447,000 | 225,000 | 2,628,000 | 3,978,000 | 1,524,000 | 3,241,000 | 1,654,000 | 2,779,000 | 4,054,692 | 4,208,892 | 6,215,706 | 5,582,272 | 4,914,780 |
| Tax | -1,732,000 | -1,499,000 | -1,510,000 | -92,000 | -23,000 | -692,000 | 286,000 | -135,000 | 180,000 | -424,000 | -825,744 | -1,032,976 | -1,690,024 | -1,753,488 | -1,329,602 |
| Profit After Tax | 14,093,000 | 14,999,000 | 3,937,000 | 133,000 | 2,605,000 | 3,286,000 | 1,810,000 | 3,106,000 | 1,834,000 | 2,355,000 | 3,228,948 | 3,175,916 | 4,525,682 | 3,828,784 | 3,585,178 |
| Dividends Paid | 1,500,000 | 3,000,000 | 4,100,000 | 3,800,000 | 3,400,000 | ||||||||||
| Retained Profit | 14,093,000 | 14,999,000 | 3,937,000 | 133,000 | 2,605,000 | 3,286,000 | 1,810,000 | 3,106,000 | 1,834,000 | 2,355,000 | 1,728,948 | 175,916 | 425,682 | 28,784 | 185,178 |
| Employee Costs | 18,551,000 | 14,790,000 | 11,557,000 | 10,295,000 | 10,429,000 | 9,160,000 | 7,748,000 | 6,747,000 | 6,647,000 | 3,926,000 | 5,739,378 | 5,075,476 | 4,670,443 | 3,906,162 | 3,447,270 |
| Number Of Employees | 343 | 301 | 259 | 246 | 227 | 212 | 212 | 194 | 190 | 173 | 167 | 174 | 168 | 146 | 131 |
| EBITDA* | 21,754,000 | 20,403,000 | 9,631,000 | 4,559,000 | 6,744,000 | 7,238,000 | 4,347,000 | 4,986,000 | 2,811,000 | 698,023,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 16,948,000 | 16,806,000 | 24,305,000 | 26,225,000 | 28,329,000 | 24,848,000 | 26,401,000 | 27,141,000 | 24,476,000 | 4,103,000 | 2,882,773 | 1,990,200 | 1,638,600 | 1,853,835 | 1,222,458 |
| Intangible Assets | 298,498,000 | 20,327,000 | 11,180,000 | 9,117,000 | 7,834,000 | 6,405,000 | 4,914,000 | 3,268,000 | 1,806,000 | ||||||
| Investments & Other | 8,597,000 | 8,321,000 | 8,321,000 | 6,080,000 | 6,084,000 | 1,720,000 | 1,720,000 | 1,720,000 | 1,720,000 | 1,720,000 | |||||
| Debtors (Due After 1 year) | 1,330,000 | ||||||||||||||
| Total Fixed Assets | 324,043,000 | 45,454,000 | 45,136,000 | 41,422,000 | 42,247,000 | 32,973,000 | 33,035,000 | 32,129,000 | 28,002,000 | 5,823,000 | 2,882,773 | 1,990,200 | 1,638,600 | 1,853,835 | 1,222,458 |
| Stock & work in progress | 11,864,000 | 7,895,000 | 7,774,000 | 8,208,000 | 7,491,000 | 6,760,000 | 5,616,000 | 5,438,000 | 3,439,000 | 2,867,000 | 3,661,761 | 4,128,066 | 3,060,722 | 2,698,305 | 2,153,077 |
| Trade Debtors | 77,213,000 | 6,603,000 | 5,389,000 | 11,675,000 | 11,768,000 | 9,582,000 | 5,293,000 | 5,511,000 | 5,089,000 | 4,895,000 | 4,056,576 | 3,352,844 | 3,913,634 | 3,130,385 | 2,454,334 |
| Group Debtors | 50,948,000 | 9,132,000 | 711,000 | 720,000 | 956,000 | 2,022,000 | 517,000 | 901,000 | 519,764 | 385,461 | 423,663 | 392,682 | 330,438 | ||
| Misc Debtors | 1,056,000 | 1,088,000 | 1,024,000 | 680,000 | 670,000 | 1,209,000 | 915,000 | 651,000 | 1,874,000 | 368,676 | 293,214 | 191,734 | 115,315 | 102,442 | |
| Cash | 21,102,000 | 6,028,000 | 5,731,000 | 5,301,000 | 4,567,000 | 4,202,000 | 1,949,000 | 501,000 | 621,000 | 54,851 | 26,651 | 18,800 | 19,300 | 17,300 | |
| misc current assets | |||||||||||||||
| total current assets | 110,179,000 | 72,530,000 | 29,114,000 | 26,919,000 | 25,226,000 | 22,170,000 | 16,089,000 | 12,381,000 | 9,680,000 | 11,158,000 | 8,661,628 | 8,186,236 | 7,608,553 | 6,355,987 | 5,057,591 |
| total assets | 434,222,000 | 117,984,000 | 74,250,000 | 68,341,000 | 67,473,000 | 55,143,000 | 49,124,000 | 44,510,000 | 37,682,000 | 16,981,000 | 11,544,401 | 10,176,436 | 9,247,153 | 8,209,822 | 6,280,049 |
| Bank overdraft | 31,000 | 72,209 | 19,734 | 17,558 | 41,767 | 147,869 | |||||||||
| Bank loan | 750,000 | ||||||||||||||
| Trade Creditors | 365,365,000 | 1,526,000 | 1,640,000 | 1,335,000 | 1,287,000 | 1,686,000 | 1,810,000 | 1,715,000 | 1,329,000 | 4,419,000 | 1,285,029 | 1,023,316 | 1,292,362 | 1,326,854 | 798,463 |
| Group/Directors Accounts | 61,661,000 | 37,645,000 | 37,070,000 | 34,051,000 | 30,319,000 | 28,945,000 | 25,238,000 | 15,305,000 | 2,763,000 | 3,086,627 | 3,211,886 | 2,376,640 | 2,157,870 | 1,090,712 | |
| other short term finances | 937,000 | 537,000 | |||||||||||||
| hp & lease commitments | 1,102,000 | 846,000 | 1,049,000 | 1,429,000 | 874,000 | 832,000 | 785,000 | 174,000 | |||||||
| other current liabilities | 5,243,000 | 1,718,000 | 2,543,000 | 3,685,000 | 2,485,000 | 1,100,000 | 1,439,000 | 1,617,000 | 2,083,000 | 1,739,865 | 2,289,776 | 2,932,785 | 2,481,205 | 2,069,663 | |
| total current liabilities | 365,365,000 | 70,469,000 | 41,849,000 | 41,997,000 | 40,452,000 | 35,364,000 | 32,687,000 | 29,745,000 | 19,175,000 | 9,265,000 | 6,183,730 | 6,544,712 | 6,619,345 | 6,007,696 | 4,106,707 |
| loans | 8,287,000 | ||||||||||||||
| hp & lease commitments | 10,276,000 | 4,822,000 | 4,505,000 | 4,549,000 | 5,376,000 | 1,433,000 | 1,972,000 | 2,110,000 | 671,000 | ||||||
| Accruals and Deferred Income | 671,000 | ||||||||||||||
| other liabilities | 985,000 | ||||||||||||||
| provisions | 3,095,000 | 2,466,000 | 2,485,000 | 1,306,000 | 618,000 | 595,000 | |||||||||
| total long term liabilities | 13,371,000 | 7,288,000 | 7,975,000 | 5,855,000 | 6,665,000 | 2,028,000 | 1,972,000 | 2,110,000 | 8,958,000 | ||||||
| total liabilities | 378,736,000 | 77,757,000 | 49,824,000 | 47,852,000 | 47,117,000 | 37,392,000 | 34,659,000 | 31,855,000 | 28,133,000 | 9,265,000 | 6,183,730 | 6,544,712 | 6,619,345 | 6,007,696 | 4,106,707 |
| net assets | 55,486,000 | 40,227,000 | 24,426,000 | 20,489,000 | 20,356,000 | 17,751,000 | 14,465,000 | 12,655,000 | 9,549,000 | 7,716,000 | 5,360,671 | 3,631,724 | 2,627,808 | 2,202,126 | 2,173,342 |
| total shareholders funds | 55,486,000 | 40,227,000 | 24,426,000 | 20,489,000 | 20,356,000 | 17,751,000 | 14,465,000 | 12,655,000 | 9,549,000 | 7,716,000 | 5,360,671 | 3,631,724 | 2,627,808 | 2,202,126 | 2,173,342 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 17,370,000 | 16,652,000 | 5,616,000 | 421,000 | 2,860,000 | 4,086,000 | 1,693,000 | 3,315,000 | 1,793,000 | 2,779,000 | |||||
| Depreciation | 2,995,000 | 2,932,000 | 3,125,000 | 3,347,000 | 3,188,000 | 2,668,000 | 2,369,000 | 1,464,000 | 923,000 | 695,244,000 | 615,769 | 525,468 | 492,064 | 409,538 | 281,592 |
| Amortisation | 1,389,000 | 819,000 | 890,000 | 791,000 | 696,000 | 484,000 | 285,000 | 207,000 | 95,000 | ||||||
| Tax | -1,732,000 | -1,499,000 | -1,510,000 | -92,000 | -23,000 | -692,000 | 286,000 | -135,000 | 180,000 | -424,000 | -825,744 | -1,032,976 | -1,690,024 | -1,753,488 | -1,329,602 |
| Stock | 3,969,000 | 121,000 | -434,000 | 717,000 | 731,000 | 1,144,000 | 178,000 | 1,999,000 | 572,000 | -794,761 | -466,305 | 1,067,344 | 362,417 | 545,228 | 2,153,077 |
| Debtors | 18,606,000 | 41,668,000 | 3,529,000 | 242,000 | 1,960,000 | 2,684,000 | 1,581,000 | 1,203,000 | -1,930,000 | 2,724,984 | 913,497 | -497,512 | 890,649 | 751,168 | 2,887,214 |
| Creditors | 363,839,000 | -114,000 | 305,000 | 48,000 | -399,000 | -124,000 | 95,000 | 386,000 | -3,090,000 | 3,133,971 | 261,713 | -269,046 | -34,492 | 528,391 | 798,463 |
| Accruals and Deferred Income | -5,243,000 | 3,525,000 | -825,000 | -1,813,000 | 1,871,000 | 1,385,000 | -339,000 | -178,000 | -466,000 | 343,135 | -549,911 | -643,009 | 451,580 | 411,542 | 2,069,663 |
| Deferred Taxes & Provisions | 629,000 | -19,000 | 1,179,000 | 688,000 | 23,000 | 595,000 | |||||||||
| Cash flow from operations | 356,672,000 | -19,493,000 | 5,685,000 | 2,431,000 | 5,525,000 | 4,574,000 | 2,630,000 | 1,857,000 | 793,000 | 699,145,883 | |||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | 276,000 | 2,241,000 | -4,000 | 4,364,000 | 1,720,000 | ||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | -750,000 | 750,000 | |||||||||||||
| Group/Directors Accounts | -61,661,000 | 24,016,000 | 575,000 | 3,019,000 | 3,732,000 | 1,374,000 | 3,707,000 | 9,933,000 | 12,542,000 | -323,627 | -125,259 | 835,246 | 218,770 | 1,067,158 | 1,090,712 |
| Other Short Term Loans | -937,000 | 937,000 | -537,000 | 537,000 | |||||||||||
| Long term loans | -8,287,000 | 8,287,000 | |||||||||||||
| Hire Purchase and Lease Commitments | 4,352,000 | 573,000 | -247,000 | -1,207,000 | 4,498,000 | -497,000 | -91,000 | 2,050,000 | 845,000 | ||||||
| other long term liabilities | -985,000 | 985,000 | |||||||||||||
| share issue | |||||||||||||||
| interest | -1,545,000 | -154,000 | -169,000 | -196,000 | -232,000 | -108,000 | -169,000 | -74,000 | -139,000 | ||||||
| cash flow from financing | -58,625,000 | 25,189,000 | 1,144,000 | 1,616,000 | 7,998,000 | 769,000 | 2,910,000 | 3,409,000 | 22,284,000 | -323,298 | 1,663,246 | 218,770 | 3,078,876 | ||
| cash and cash equivalents | |||||||||||||||
| cash | 15,074,000 | 297,000 | 430,000 | 734,000 | 365,000 | 2,253,000 | 1,949,000 | -501,000 | -120,000 | 566,149 | 28,200 | 7,851 | -500 | 2,000 | 17,300 |
| overdraft | -31,000 | 31,000 | -72,209 | 52,475 | 2,176 | -24,209 | -106,102 | 147,869 | |||||||
| change in cash | 15,074,000 | 297,000 | 430,000 | 734,000 | 365,000 | 2,253,000 | 1,980,000 | -532,000 | -120,000 | 638,358 | -24,275 | 5,675 | 23,709 | 108,102 | -130,569 |
rayner intraocular lenses limited Credit Report and Business Information
Rayner Intraocular Lenses Limited Competitor Analysis
Perform a competitor analysis for rayner intraocular lenses limited by selecting its closest rivals, whether from the MANUFACTURING sector, other large companies, companies in BN14 area or any other competitors across 12 key performance metrics.
rayner intraocular lenses limited Ownership
RAYNER INTRAOCULAR LENSES LIMITED group structure
Rayner Intraocular Lenses Limited has no subsidiary companies.
Ultimate parent company
2 parents
RAYNER INTRAOCULAR LENSES LIMITED
00615539
rayner intraocular lenses limited directors
Rayner Intraocular Lenses Limited currently has 3 directors. The longest serving directors include Mr Alan Hemmant (Mar 2023) and Mr Timothy Clover (Mar 2023).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Alan Hemmant | United Kingdom | 43 years | Mar 2023 | - | Director |
| Mr Timothy Clover | United Kingdom | 58 years | Mar 2023 | - | Director |
| Mr David Allan | England | 60 years | May 2023 | - | Director |
P&L
December 2023turnover
65.9m
+20%
operating profit
17.4m
+4%
gross margin
62%
-13.47%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
55.5m
+0.38%
total assets
434.2m
+2.68%
cash
21.1m
+2.5%
net assets
Total assets minus all liabilities
rayner intraocular lenses limited company details
company number
00615539
Type
Private limited with Share Capital
industry
32500 - Manufacture of medical and dental instruments and supplies
incorporation date
November 1958
age
67
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
graham grant & co.limited (December 1978)
accountant
-
auditor
DELOITTE LLP
address
10 dominion way, worthing, west sussex, BN14 8AQ
Bank
NATIONAL WESTMINSTER BANK PLC
Legal Advisor
-
rayner intraocular lenses limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 6 charges/mortgages relating to rayner intraocular lenses limited. Currently there are 3 open charges and 3 have been satisfied in the past.
rayner intraocular lenses limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for RAYNER INTRAOCULAR LENSES LIMITED. This can take several minutes, an email will notify you when this has completed.
rayner intraocular lenses limited Companies House Filings - See Documents
| date | description | view/download |
|---|
